|
Summary Information: Galmed Pharmaceuticals Ltd. Ordinary Shares NASDAQ:GLMD |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.
__The following are links to various summary and news pages for __Galmed Pharmaceuticals Ltd. Ordinary Shares [ GLMD ]. __Note: Some Links might not have information for the company. |
|